1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Global Deep Brain Stimulation Market 2016-2020

Global Deep Brain Stimulation Market 2016-2020

  • April 2016
  • -
  • Infiniti Research Limited
  • -
  • 61 pages

Summary

Table of Contents

Search Inside

About Deep Brain Stimulation

A neurostimulation system, also known as a neurostimulator, provides therapeutic activation or modulation in the nervous system at targeted anatomical sites. Deep brain stimulation (DBS) system, a type of neurostimulator, generates electrical stimulation to the targeted areas of the brain and regulates the electrical signals that are generated by the diseased brain cells and neurons.

Technavio’s analysts forecast the global DBS market to grow at a CAGR of 10.59% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global DBS market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various types of DBS systems.


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Deep Brain Stimulation Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Key vendors
- Boston Scientific Corp.
- Medtronic plc
- St. Jude Medical Inc.


Other prominent vendors
- Adaptive Neuromodulation
- Aleva Neurotherapeutics
- Beijing Pins Medical
- NeuroPace
- NeuroSigma

Market driver
- Increased number of market approvals
- For a full, detailed list, view our report

Market challenge
- High cost of DBS therapy
- For a full, detailed list, view our report

Market trend
- Hybrid neuroprosthetic devices
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...

Epiomic Epidemiology Series: Bell’s Palsy Forecast in 15 Major Markets 2017-2027

Epiomic Epidemiology Series: Bell’s Palsy Forecast in 15 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • February 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Bell’s palsy in 15 Major Markets Bell's palsy, also known as idiopathic facial nerve palsy, is a weakness of the muscles on one side ...

Epiomic Epidemiology Series: Muscular Dystrophies Forecast in 12 Major Markets 2017-2027

Epiomic Epidemiology Series: Muscular Dystrophies Forecast in 12 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • January 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Muscular Dystrophies in 12 Major Markets The muscular dystrophies (MD) are a group of more than 30 genetic diseases characterized by ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.